The CFP component should restore control of all resistant mosquito populations due to its novel mode of action of disrupting respiration pathways (oxidative phosphorylation) in mitochondria [35], and lack of cross-resistance to known mechanisms in malaria vectors [24], [36], [37]. The gene discussed is CFP; the disease is malaria.